Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Home infusion therapy ideally have major focus for providing complex pharmaceutical products to patient using different home infusion therapy products and device like infusion pump, intravenous sets, IV cannulas, and needleless connectors. It provide potential benefits including health care cost, patient and caregiver convenience and decreases the time spent in hospital. The market provides an ability most convenient way for getting therapy and medication at home itself. Also, growing aging population and rising burden of different chronic diseases, and increasing adoption of home infusion therapy among population is major factor accelerating the demand for market. The home infusion therapy market is expected to witness the growth at rapid pace during the estimated time period.
The United States home infusion therapy market is driven by different factors like emerging geriatric population, rising incidence of chronic diseases across the country has fuelled the demand for market to huge extend. Besides, increasing preference for home infusion therapy in long term care of chronic diseases is accelerating the demand for market. Similarly, rapid advancement and increasing technological advancement in home infusion therapy products is propelling the growth of market to huge extend. Likewise, the market is widely adopted in the country owing its advantages for patient care and cost effectiveness is key factor accelerating the demand for market. In addition, burden of different chronic diseases like cancer, cardiovascular diseases, and diabetes is major factor for the market growth in the region.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the United States home infusion therapy market. In addition, complete analysis of changes on United States home infusion therapy market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The United States home infusion therapy market is expected to witness moderately positive growth for market
The home infusion therapy market comprises of different market segment like product, application.
The United States home infusion therapy is available in market according different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. The infusion pump is expected to register major market share in the United States home infusion therapy market owing to its different features as it helps to facilitates in infusing fluids to a patient’s body with close monitoring. The medication range from infusing antibiotics, insulin and other hormones, chemotherapy drugs. Likewise, needleless connectors are anticipated to rising demand in market as these provide a safe way to access and are commonly used to administer fluids, and medication. It greatly reduces the risk of needle stick injuries and also allow needleless connection of syringe.
The home infusion therapy market finds its major application in anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition and others. The anti-infective is expected to gain major market share in home infusion therapy market owing to increasing number of patient demanding for therapy in anti-infective as it is mainly used for inhibiting the spread of infectious diseases or chronic diseases. Besides, growing awareness for home infusion therapy and anti-infective therapy mostly consist of different intravenous (IV) antibiotics, intramuscular (IM) antibiotics, antifungal and/or antiviral. These are widely used to treat a wide variety of minor to severe infection and are most commonly prescribed home infusion therapy. Likewise, endocrinology is having emerging demand for home infusion therapy specifically due to increasing number of diabetes patient in United States. Similarly, hydration therapy is expected to witness the growth at rapid pace during the estimated time period.
The key players in home infusion therapy market are B. Braun Melsungen AG, Becton, Dickinson and Company (BD) , NewIV , ICU Medical Inc, Plenum Tech Pvt Ltd, Baxter International Inc, JMS Co. Ltd, Silverline Meditech Pvt Ltd, Eli Lilly and Company , Fresenius Kabi, Terumo Corporation and AKAS Medical among others
Recent Developments:
April 2021: Medtronic had unveiled its extended infusion set, the first set that can be worn to deliver insulin for up to seven days in selected European countries. Infusion sets are tubing that provides insulin to the body form a pump and then usually need to be changed every few days. The extended infusion set doubles the times a set can be worn, it allows user to safely stay on insulin pump therapy with fewer interruption and insertion while providing improved convince for diabetes management routines.
April 2020: B.Braun Medical Inc had announced the US Food and Drug administration issued Emergency use authorization of B. Braun’s perfusor space syringe infusion pump, infusomat space volumetric infusion pump and outlook ES pump system for use in the tracheal delivery of continuous nebulized medication into nebulizer to treat patient of all ages with or suspended of having Coronavirus diseases.
October 2017: BioScrip, Inc had announced that it can now dispense and administer Radicava (edaravone), the first treatment option for amyotrophic lateral sclerosis(ALS) approved by the U.S. Food and Drug Administration (FDA) in more than 20 years. Radicava is commercialized in U.S. by Mitsubishi Tanabe Pharma America, Inc.
The report analyses the United States home infusion therapy market based on by product, application. The United States home infusion therapy is available in market according different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. The infusion pump is expected to register major market share in the United States home infusion therapy market. The home infusion therapy market finds its major application in anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition and others. The anti-infective is expected to gain major market share in home infusion therapy market owing to increasing number of patient demanding for therapy in anti-infective as it is mainly used for inhibiting the spread of infectious diseases or chronic diseases.
Why to buy this report:
